{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:12:12Z","timestamp":1790266332203,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T00:00:00Z","timestamp":1775260800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019717","name":"AstraZeneca Pharmaceutical Spain","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019717","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","esmorwd.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Real World Data and Digital Oncology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.esmorw.2026.100716","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:30:55Z","timestamp":1784068255000},"page":"100716","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Applying clinical natural language processing to lung cancer in Spain: a terminology-based panel approach"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4992-4306","authenticated-orcid":false,"given":"A.","family":"Ospina-Serrano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Azk\u00e1rate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ram\u00edrez-Peinado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.-K.","family":"Vollan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2588-6405","authenticated-orcid":false,"given":"S.","family":"Menke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5053-257X","authenticated-orcid":false,"given":"M.","family":"Posso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Taberna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.esmorw.2026.100716_bib1","first-page":"278","article-title":"The epidemiological landscape of lung cancer: current status, temporal trend and future projections based on the latest estimates from GLOBOCAN 2022","volume":"5","author":"Ji","year":"2025","journal-title":"J Natl Cancer Cent"},{"key":"10.1016\/j.esmorw.2026.100716_bib2","series-title":"Global Cancer Observatory","author":"Ferlay","year":"2022"},{"issue":"8","key":"10.1016\/j.esmorw.2026.100716_bib3","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.mayocp.2019.01.013","article-title":"Non-small cell lung cancer: epidemiology, screening, diagnosis, and treatment","volume":"94","author":"Duma","year":"2019","journal-title":"Mayo Clinic Proc"},{"issue":"1","key":"10.1016\/j.esmorw.2026.100716_bib4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3892\/mco.2014.410","article-title":"Specific organ metastases and survival in metastatic non-small-cell lung cancer","volume":"3","author":"Tamura","year":"2015","journal-title":"Mol Clin Oncol"},{"issue":"20","key":"10.1016\/j.esmorw.2026.100716_bib5","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.3390\/cells11203200","article-title":"Biomarker-targeted therapies in non-small cell lung cancer: current status and perspectives","volume":"11","author":"Guo","year":"2022","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.esmorw.2026.100716_bib6","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.cllc.2018.02.002","article-title":"Treatment patterns and clinical outcomes among metastatic non-small-cell lung cancer patients treated in the community practice setting","volume":"19","author":"Nadler","year":"2018","journal-title":"Clin Lung Cancer"},{"issue":"4","key":"10.1016\/j.esmorw.2026.100716_bib7","doi-asserted-by":"crossref","first-page":"249","DOI":"10.6004\/jnccn.2204.0023","article-title":"Non-small cell lung cancer, version 4.2024, NCCN clinical practice guidelines in oncology","volume":"22","author":"Riely","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"10.1016\/j.esmorw.2026.100716_bib8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/1759-7714.13272","article-title":"Immunotherapy at any line of treatment improves survival in patients with advanced metastatic non-small cell lung cancer (NSCLC) compared with chemotherapy (Quijote-CLICaP)","volume":"11","author":"Ruiz-Pati\u00f1o","year":"2020","journal-title":"Thorac Cancer"},{"issue":"12","key":"10.1016\/j.esmorw.2026.100716_bib9","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1515\/cclm-2022-0291","article-title":"Artificial intelligence in clinical applications for lung cancer: diagnosis, treatment and prognosis","volume":"60","author":"Pei","year":"2022","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"10.1016\/j.esmorw.2026.100716_bib10","doi-asserted-by":"crossref","DOI":"10.2196\/35475","article-title":"Using natural language processing and machine learning to preoperatively predict lymph node metastasis for non-small cell lung cancer with electronic medical records: development and validation study","volume":"10","author":"Hu","year":"2022","journal-title":"JMIR Med Inform"},{"issue":"7","key":"10.1016\/j.esmorw.2026.100716_bib11","doi-asserted-by":"crossref","DOI":"10.2196\/20492","article-title":"Assessing the performance of clinical natural language processing systems: development of an evaluation methodology","volume":"9","author":"Canales","year":"2021","journal-title":"JMIR Med Inform"},{"key":"10.1016\/j.esmorw.2026.100716_bib12","first-page":"8","article-title":"Savana: re-using electronic health records with artificial intelligence","volume":"4","author":"Hern\u00e1ndez Medrano","year":"2017","journal-title":"Int J Interact Multimed Artif Intell"},{"issue":"1","key":"10.1016\/j.esmorw.2026.100716_bib13","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12911-023-02301-5","article-title":"Negation recognition in clinical natural language processing using a combination of the NegEx algorithm and a convolutional neural network","volume":"23","author":"Arg\u00fcello-Gonz\u00e1lez","year":"2023","journal-title":"BMC Med Inform Decis Mak"},{"key":"10.1016\/j.esmorw.2026.100716_bib14","series-title":"Principles of Health Interoperability HL7 and SNOMED","author":"Benson","year":"2012"},{"key":"10.1016\/j.esmorw.2026.100716_bib15","article-title":"Artificial intelligence in oncology: ensuring safe and effective integration of language models in clinical practice","volume":"46","author":"Verlingue","year":"2024","journal-title":"Lancet Reg Health Eur"},{"issue":"3","key":"10.1016\/j.esmorw.2026.100716_bib16","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/jamia\/ocaa269","article-title":"Ambiguity in medical concept normalization: An analysis of types and coverage in electronic health record datasets","volume":"28","author":"Newman-Griffis","year":"2021","journal-title":"J Am Med Inform Assoc"},{"key":"10.1016\/j.esmorw.2026.100716_bib17","series-title":"A short review of ethical challenges in clinical natural language processing. Proceedings of the First ACL Workshop on Ethics in Natural Language Processing","first-page":"80","author":"\u0160uster","year":"2017"},{"issue":"1","key":"10.1016\/j.esmorw.2026.100716_bib18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13326-018-0179-8","article-title":"Clinical natural language processing in languages other than English: opportunities and challenges","volume":"9","author":"N\u00e9v\u00e9ol","year":"2018","journal-title":"J Biomed Semantics"},{"key":"10.1016\/j.esmorw.2026.100716_bib19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13045-023-01456-y","article-title":"The artificial intelligence and machine learning in lung cancer immunotherapy","volume":"16","author":"Gao","year":"2023","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.esmorw.2026.100716_bib20","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.3390\/cancers15215236","article-title":"Artificial intelligence and lung cancer: impact on improving patient outcomes","volume":"15","author":"Gandhi","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.esmorw.2026.100716_bib21","doi-asserted-by":"crossref","DOI":"10.1177\/14604582221146709","article-title":"Prescreening in oncology trials using medical records. Natural language processing applied on lung cancer multidisciplinary team meeting reports","volume":"29","author":"Ansoborlo","year":"2023","journal-title":"Health Informatics J"},{"issue":"suppl 5","key":"10.1016\/j.esmorw.2026.100716_bib22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s12911-019-0931-8","article-title":"Natural language processing for populating lung cancer clinical research data","volume":"19","author":"Wang","year":"2019","journal-title":"BMC Med Inform Decis Mak"},{"key":"10.1016\/j.esmorw.2026.100716_bib23","article-title":"Validation of non-small cell lung cancer clinical insights using a generalized oncology natural language processing model","volume":"8","author":"Kenney","year":"2024","journal-title":"JCO Clin Cancer Inform"},{"key":"10.1016\/j.esmorw.2026.100716_bib24","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3390\/biomedinformatics4010015","article-title":"Deep machine learning for medical diagnosis, application to lung cancer detection: a review","volume":"4","author":"Gayap","year":"2024","journal-title":"BioMedInformatics"},{"issue":"23","key":"10.1016\/j.esmorw.2026.100716_bib25","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.3390\/cancers16234004","article-title":"Real-world evidence on adverse events and healthcare resource utilization in patients with chronic lymphocytic leukaemia in Spain using natural language processing: the SRealCLL study","volume":"16","author":"Abrisqueta-Costa","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"16","key":"10.1016\/j.esmorw.2026.100716_bib26","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.3390\/cancers15164047","article-title":"Real-world evidence on the clinical characteristics and management of patients with chronic lymphocytic leukemia in Spain using natural language processing: the SRealCLL study","volume":"15","author":"Loscertales","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"20","key":"10.1016\/j.esmorw.2026.100716_bib27","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.3390\/cancers15204909","article-title":"Applying natural language processing to single-report prediction of metastatic disease response using the OR-RADS lexicon","volume":"15","author":"Elbatarny","year":"2023","journal-title":"Cancers (Basel)"}],"container-title":["ESMO Real World Data and Digital Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949820126000354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949820126000354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:42:00Z","timestamp":1790264520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949820126000354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":27,"alternative-id":["S2949820126000354"],"URL":"https:\/\/doi.org\/10.1016\/j.esmorw.2026.100716","relation":{},"ISSN":["2949-8201"],"issn-type":[{"value":"2949-8201","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Applying clinical natural language processing to lung cancer in Spain: a terminology-based panel approach","name":"articletitle","label":"Article Title"},{"value":"ESMO Real World Data and Digital Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmorw.2026.100716","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100716"}}